A 'game-changer': By studying animal health, researchers find improved ways for developing, testing cancer therapies
(Medical Xpress) -- A group of Kansas State University researchers has made valuable findings in the search for cancer's cure.
Cancer
Aug 15, 2012 |
not rated yet |
0
Scientists: Novel TB drug combo passes first test
Scientists are hot on the trail of a new tuberculosis treatment that a small study suggests might one day offer an alternative to battle this deadly lung disease, even if it is resistant to today's two main drugs.
Diseases, Conditions, Syndromes
Jul 23, 2012 |
not rated yet |
0
Trial signals major milestone in hunt for new TB drugs
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two ...
Diseases, Conditions, Syndromes
Jul 23, 2012 |
not rated yet |
0
Afinitor approved for advanced breast cancer
(HealthDay) -- Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food ...
Medications
Jul 23, 2012 |
not rated yet |
0
Next front in worldwide AIDS battle: Stretching use of anti-HIV drugs
(Medical Xpress) -- A Johns Hopkins expert in the drug treatment of HIV disease and AIDS is spearheading an international effort to radically shift the manufacturing and prescribing of combination therapies widely credited ...
HIV & AIDS
Jul 06, 2012 |
not rated yet |
0
|
In vitro study identifies potential combination therapy for breast cancer
A study conducted at Boston University School of Medicine (BUSM) demonstrates an effective combination therapy for breast cancer cells in vitro. The findings, published in the July 2012 issue of Anticancer Research, raise ...
Cancer
Jul 02, 2012 |
not rated yet |
0
|
Drug combo much better than AZT alone at preventing mother-to-infant HIV transmission
Non-breastfed babies born to HIV-positive mothers who didn't receive antiretroviral therapy during pregnancy are routinely given zidovudine, commonly known as AZT, shortly after birth to prevent mother-to-child transmission ...
HIV & AIDS
Jun 20, 2012 |
not rated yet |
0
|
Combination therapy for triple-negative breast cancer disappointing
(Medical Xpress) -- A recent clinical trial testing a combination therapy for basal-like (also known as triple-negative) breast cancer demonstrates that a combination of two drugs with promising preclinical ...
Cancer
Jun 13, 2012 |
not rated yet |
0
|
Psychostimulant users seek information, not drugs, online
Australian illicit drug users are turning to the internet for drug education, but not to buy drugs.
Addiction
Jun 05, 2012 |
not rated yet |
0
Scientists see potential in novel leukemia treatment
Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib kill ...
Cancer
May 22, 2012 |
5 / 5 (3) |
0
First, do no harm: Study finds danger in standard treatment for a serious lung disease
A combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, called ...
Diseases, Conditions, Syndromes
May 20, 2012 |
not rated yet |
0
|
Fewer suicides after antidepressive treatment for schizophrenia
(Medical Xpress) -- Antidepressive drugs reduce the mortality rate of schizophrenic patients, while treatment with bensodiazepines greatly increases it, especially as regards suicide. Giving several antipsychotics simultaneously, ...
Psychology & Psychiatry
May 08, 2012 |
not rated yet |
0
Advances in personalized medicine for lung cancer
Several new studies that may help doctors tailor lung cancer treatment to the characteristics of individual patients and of their tumors are being presented at the 3rd European Lung Cancer Conference in Geneva.
Cancer
Apr 18, 2012 |
5 / 5 (1) |
0
Giving preventive drug to men at high risk for HIV would be cost-effective, study shows
A once-a-day pill to help prevent HIV infection could significantly reduce the spread of AIDS, but only makes economic sense if used in select, high-risk groups, Stanford University researchers conclude in a new study.
HIV & AIDS
Apr 16, 2012 |
not rated yet |
0
|
Drug approved to treat high blood pressure
(HealthDay) -- The high blood pressure drug Toprol XL has been combined with a low-dose diuretic to form Dutoprol (metoprolol succinate extended release/hyrdrochlorothiazide), which has been approved by the U.S. Food and ...
Medications
Apr 13, 2012 |
not rated yet |
0
